Czech Republic

 

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.

HBI 2023: The outpatient differential

For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.

Is Orpea set to sell up in Belgium?

Multiple sources tell HBI that French nursing home operator Orpea is looking to sell up in Belgium, as it looks to sell off a chunk of its 1.2bn real estate portfolio. HBI also hears more speculation on the ongoing country-by-country review.

PP in Valencia defends Alzira model

For-profit hospital group Ribera Salud says that having won the May 2023 elections, the new Partido Popular (PP) administration in Valencia is keen to protect and grow the Alzira model that was being dismantled by the previous leftist government. Meanwhile, Ribera is growing in the Middle East.

Digital health booming in CEE

Digital health is booming in Central and Eastern Europe (CEE), boosted by several countries in the region introducing major policy initiatives to integrate telehealth solutions and digitise their health systems. CEE-based multinational law firm Kinstellar spells this out in its latest ‘Current eHealth trends in CEE and Turkey’ report.

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Penta buys one for the future in Poland

Czech-Slovak investment group Penta has acquired Polish hospital group Grupa Nowy Szpital (GNS). With this, Penta is making further inroads into the tricky Polish market. HBI asks, given the state of the Polish market, is now really the right time to buy?

MidEuropa buys Optegra

UK, Czechia and Poland-based ophthalmology company Optegra has found a buyer - PE firm MidEuropa has reached a definitive agreement to acquire a majority stake while management and current owners H2 will retain minority stakes.

Orpea pledges to pay in full as restructuring rumours continue

French elderly care giant Orpea continues to hit the headlines for all the wrong reasons. Over the last week, dozens of facilities were raided by the French authorities, talk continues to be rife about restructuring and potential exits, and contrary to previous assertions HBI understands the group now intends to pay back the full €56m owed to the state.

FutureLife enters Spain and Italy

FutureLife, the Czech Republic-based fertility company, has entered Spain and Italy with its latest acquisition. Owned by PE companies CVC and Hartenberg holding, the group has acquired Institut Marquès (IM), an assisted reproduction company based in Barcelona with clinics in Spain and Italy.

Find Us